New strategies for the management of acute decompensated heart failure

Current Opinion in Cardiology

Volumn 16, Issue 3, 2001, Pages 164-173

  Koerner, Michael M ^a   Loebe, Matthias ^a   Lisman, Kevin A ^a   Stetson, Sonny J ^a   Lafuente, Javier A ^a   Noon, George P ^a   Torre Amione, Guillermo ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ANGIOTENSIN RECEPTOR ANTAGONIST; BRAIN NATRIURETIC PEPTIDE; CALCIUM ANTAGONIST; DOBUTAMINE; DOPAMINE; ENDOTHELIN RECEPTOR ANTAGONIST; GLUCOSE; GLYCERYL TRINITRATE; IMMUNOGLOBULIN; INOTROPIC AGENT; INSULIN; MORPHINE; NESIRITIDE; NITROPRUSSIDE SODIUM; NORADRENALIN; PHOSPHODIESTERASE INHIBITOR; PRAZOSIN; TEZOSENTAN; THEOPHYLLINE; UNCLASSIFIED DRUG; VASODILATOR AGENT; VASOPRESSIN;

ACUTE HEART FAILURE; AORTA BALLOON; CLINICAL TRIAL; FORWARD HEART FAILURE; HEART FAILURE; HEART OUTPUT; HEART SURGERY; HEMOFILTRATION; HIGH OUTPUT HEART FAILURE; HUMAN; IMMUNOTHERAPY; MULTICENTER STUDY; PRIORITY JOURNAL; REVIEW; SYSTEMIC VASCULAR RESISTANCE;

ACUTE DISEASE; HEART FAILURE, CONGESTIVE; HUMANS;

EID: 0035017804     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001573-200105000-00002     Document Type: Review

References (77)

1. Report of the American Cardiology/American Heart Association task force on practice guidelines (Committee on evaluation and management of heart failure)
2. Maximizing management of patients with decompensated heart failure
3. Non-transplant surgery for heart failure
4. High-sensitivity C-reactive protein: A novel and promising marker of coronary heart disease
5. Myocarditis
6. Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy
7. Pyrexia, procalcitonin, immune activation and survival in cardiogenic shock: The potential importance of bacterial translocation
8. Intraaortic ballon pumping for predominantly right ventricular failure after heart transplantation
9. Mechanical circulatory support after orthotopic heart transplantation
10. Type A lactic acidosis in cardiogenic shock
11. Plasma brain natriuretic peptide-an independent predictor of cardiovascular mortality in acute heart failure
12. Effects of cardiogenic shock on lactate and glucose metabolism after heart surgery
13. Lactic acidosis update for critical care clinicians
14. The effectiveness of right heart catheterization in the initial care of critically ill patients. SUPPORT investigators
15. Cardiogenic shock
16. Trends in cardiogenic shock: Report from the SHOCK study
17. Reference guide to cardiogenic shock complicating acute myocardial infarction
18. Current medical therapy for advanced heart failure
19. Cardiogenic shock
20. Arginine vasopressin in the treatment of 50 patients with postcardiotomy vasodilatory shock
21. Long-term administration of atrial natriuretic peptide in patients with acute heart failure
22. Mechanisms of disease: Hormones and hemodynamics in heart failure
23. Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure
24. Results of targeted antitumor necrosis factor therapy with etanercept (ENBREL) in patients with advanced heart failure
25. Endothelins and endothelin receptor antagonists
26. Hemodynamic effects of tezosentan, an intravenous dual endothelin receptor antagonist, in patients with class III to IV congestive heart failure
27. A prospective, randomized, double-blind, placebo-controlled, multi-center study of the efficacy and safety of tezosentan in patients with acute decompensated heart failure
28. Cardiac troponin I in fulminant adenovirus myocarditis treated with a 24-hour infusion of high-dose intravenous immunoglobulin
29. Effective treatment of severe acute myocarditis with intravenous immune globuline and pulse corticosteroids in a 32-year-old patient
30. Immunomodulating therapy with intravenous immunoglobulin in patients with chronic heart failure
31. Intervention in myocarditis and acute cardiomyopathy with immune globuline: Results from the randomized placebo controlled IMAC trial
32. Immunoglobulin adsorption in patients with idiopathic dilated cardiomyopathy
33. Daily hemofiltration in severe heart failure
34. Acute respiratory failure after cardiac surgery: Clinical experience with the application of continuous arteriovenous hemofiltration
35. Ventricular assist device (VAD) systems combined with continuous high volume venous-venous hemofiltration (CVVH)
36. Continuous hemofiltration for the failing heart
37. Prospective evaluation of short-term, high-volume isovolemic hemofiltration on the hemodynamic course and outcome in patients with intractable circulatory failure resulting from septic shock
38. Acute valve dysfunction with heart failure: Perioperative intensive care management and results
39. Cardiopulmonary cerebral resuscitation using emergency cardiopulmonary bypass, coronary reperfusion therapy and mild hypothermia in patients with cardiac arrest outside the hospital
40. Device selection in mechanical support
41. Mechanical circulatory support for advanced heart failure
42. Emergency mechanical circulatory support: Still viable?
43. Mechanical cardiac support 2000: Current applications and future trial design
44. Critical review of current left ventricular assist devices
45. Circulatory assist devices 2000: An update
46. Resuscitation of a near-drowning patient by use of a portable extracorporeal circulation device
47. Cardiopulmonary bypass and severe drug intoxication
48. Mechanical circulatory support for acute heart failure
49. Postcardiotomy mechanical support: Risk factors and outcome
50. Mechanical circulatory support for patients with acute-fulminant myocarditis
51. Blood pumps for circulatory support
52. A small pulsatile blood pump for ventricular support during end-stage heart failure
53. Emergency department cardiopulmonary bypass in the treatment of human cardiac arrest
54. Transport of hemodynamically unstable patients by a mobile circulatory support team
55. Management of fulminant myocarditis using circulatory support systems
56. Acute and temporary ventricular support with BioMedicus centrifugal pump
57. The use of extracorporeal life support in adult patients with primary cardiac failure as a bridge to implantable left ventricular assist device
58. Transport of patients in severe cardiogenic shock using mechanical circulatory support: Patient selection and procedure
59. Seven years of experience with the centrifugal pump in patients with cardiogenic shock
60. Extracorporeal membrane oxygenation for cardiac support in pediatric patients
61. Management of acute cardiac failure with mechanical assist: Experience with the ABIOMED BVS 5000
62. First clinical experience with the DeBakey VAD continuous-axial-flow pump for bridge to transplantation
63. Pulsatile flow in patients with a novel nonpulsatile implantable ventricular assist device
64. First permanent implant of the Jarvik 2000 heart
65. Performance of a continuous flow ventricular assist device: Magnetic bearing design, construction, and testing
66. Mechanical circulatory support with the Thoratec assist device in patients with postcardiotomy cardiogenic shock
67. Single-center experience with the thoratec ventricular assist device
68. Influence of different assist devices on survival after orthotopic heart transplantation
69. Mechanical support for acutely failed heart or lung grafts
70. Team management of patients with heart failure
71. Specialized centers for heart failure management
72. Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations
73. Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting